Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis

Ki vehet részt

• Participants must meet all of the inclusion criteria listed below to be eligible for the study:
• Age 64 years or above
• Diagnosis of primary femorotibial knee OA
• Radiographic evidence of knee OA defined as Kellgren-Lawrence (KL) grade 2 or 3 in the index knee
• Participants who are intolerant to, or have failed to adequately respond to at least 2 OA therapies
• Index knee pain assessed during the screening period and following wash-out of pain medications
• Willingness to abstain from prohibited medications/treatments during the trial
• Women who are postmenopausal (≥12 months natural amenorrhea without alternative cause) or surgically sterilized (bilateral tubal ligation, bilateral oophorectomy, or hysterectomy)
• Male participants with partners of childbearing potential, who are not surgically sterile (vasectomy) for at least 6 months prior to randomization, must use condoms with spermicide in addition to their partner's contraception from randomization and for 90 days after last dose

Ki nem vehet részt

• Recent major injury, surgical procedure, or intra-articular treatment in the index knee
• Use of medications that may interfere with pain assessment or study outcomes
• Known coagulopathy or use of anticoagulant/antiaggregant medication
• Any known history of infection or tumor of the index knee, or active infection at the intended injection site
• Any known history of inflammatory arthropathy or crystal-deposition disease
• Any severe systemic cartilage, bone, or musculoskeletal disorder that may interfere with study outcomes
• Clinically significant widespread pain syndromes
• Immunosuppressive therapy, clinically significant immunodeficiency, or active infection
• Significant uncontrolled systemic disease or clinically significant findings on screening laboratory tests or physical examination
• Participants will be excluded from the study if they meet any of the following criteria:
• Severe or end-stage osteoarthritis of the index knee
• Clinically significant structural abnormalities or instability of the index knee
• Body Mass Index (BMI) >40 kg/m²